ATE220908T1 - Intracoronarer stent der quinazolinone derivate enthält - Google Patents

Intracoronarer stent der quinazolinone derivate enthält

Info

Publication number
ATE220908T1
ATE220908T1 AT97954887T AT97954887T ATE220908T1 AT E220908 T1 ATE220908 T1 AT E220908T1 AT 97954887 T AT97954887 T AT 97954887T AT 97954887 T AT97954887 T AT 97954887T AT E220908 T1 ATE220908 T1 AT E220908T1
Authority
AT
Austria
Prior art keywords
group
intracoronary stent
quinazolinone derivatives
stent containing
containing quinazolinone
Prior art date
Application number
AT97954887T
Other languages
English (en)
Inventor
Arnon Nagler
Shimon Slavin
Eli Hazum
Israel Vlodavsky
Ehud Geller
Mark Pines
Original Assignee
Agricultural Res Org
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11916296A external-priority patent/IL119162A/xx
Application filed by Agricultural Res Org, Hadasit Med Res Service filed Critical Agricultural Res Org
Application granted granted Critical
Publication of ATE220908T1 publication Critical patent/ATE220908T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97954887T 1996-08-30 1997-08-14 Intracoronarer stent der quinazolinone derivate enthält ATE220908T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11916296A IL119162A (en) 1994-08-31 1996-08-30 Intracoronary stents containing quinazolinone derivatives
PCT/US1997/015254 WO1998023244A2 (en) 1996-08-30 1997-08-14 Intracoronary stents containing quinazolinone derivatives

Publications (1)

Publication Number Publication Date
ATE220908T1 true ATE220908T1 (de) 2002-08-15

Family

ID=11069244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97954887T ATE220908T1 (de) 1996-08-30 1997-08-14 Intracoronarer stent der quinazolinone derivate enthält

Country Status (8)

Country Link
EP (1) EP0936910B1 (de)
JP (1) JP2001500040A (de)
CN (1) CN1126534C (de)
AT (1) ATE220908T1 (de)
AU (1) AU712520B2 (de)
CA (1) CA2253362C (de)
DE (1) DE69714281T2 (de)
WO (1) WO1998023244A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014169A1 (en) 1996-09-30 1998-04-09 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US8029561B1 (en) * 2000-05-12 2011-10-04 Cordis Corporation Drug combination useful for prevention of restenosis
WO1999056663A2 (en) * 1998-05-05 1999-11-11 Scimed Life Systems, Inc. Stent with smooth ends
US6290673B1 (en) 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
AU2001294634B2 (en) 2000-10-16 2006-07-06 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US6964680B2 (en) 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US7169179B2 (en) 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
JP2007523946A (ja) * 2004-02-25 2007-08-23 コルガード バイオファーマシューティカルズ リミテッド キナゾリノンを持続放出するための生体適合性ポリマー送達システム
USD516723S1 (en) 2004-07-06 2006-03-07 Conor Medsystems, Inc. Stent wall structure
US20070160640A1 (en) * 2006-01-12 2007-07-12 Eun-Hyun Jang Halofuginone delivering vascular medical devices
CA2670590C (en) * 2006-12-01 2018-06-12 Wake Forest University Health Sciences Medical devices incorporating collagen inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5599352A (en) * 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
US5593417A (en) * 1995-11-27 1997-01-14 Rhodes; Valentine J. Intravascular stent with secure mounting means

Also Published As

Publication number Publication date
CA2253362A1 (en) 1998-06-04
CN1126534C (zh) 2003-11-05
WO1998023244A2 (en) 1998-06-04
CN1219125A (zh) 1999-06-09
DE69714281D1 (de) 2002-08-29
EP0936910B1 (de) 2002-07-24
AU712520B2 (en) 1999-11-11
JP2001500040A (ja) 2001-01-09
EP0936910A2 (de) 1999-08-25
CA2253362C (en) 2003-05-06
EP0936910A4 (de) 1999-08-25
DE69714281T2 (de) 2003-02-27
WO1998023244A3 (en) 1998-09-17
AU6755998A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
ATE220908T1 (de) Intracoronarer stent der quinazolinone derivate enthält
ATE197401T1 (de) Chinazolinon-arzneimittel sowie deren verwendung
DE69418704D1 (de) Anthranilsäure derivate
FI931061A0 (fi) Metylen-oxindolderivat och foerfarande foer deras framstaellning
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
ES2176204T3 (es) Antidepresivos que contienen un derivado de xantina.
NO933452L (no) Et terapeutisk middel for Parkinson's sykdom
DE69220037D1 (de) Acridinderivate
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
ES2123756T3 (es) Derivados de piperazina.
ATE219481T1 (de) 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative
DE69122812D1 (de) Glutathionderivat
DK0850062T3 (da) Anvendelse af halofuginon til fremstilling af et medikament til svækkelse af neovaskularisering og til behandling af maligne tumorer hos mennesker
ES2065992T3 (es) Uso de derivados de imidazopirazol como analgesicos y agentes anti-inflamatorios.
DK1110551T3 (da) Okulærtensionssænkende middel
PT1023287E (pt) Derivados da 3-oxo-2(h)-1,2,4-triazina como ligandos dos receptores 5ht1a
AR019894A1 (es) Empleo de un derivado de tetrahidroxipiridina (0 4-hidroxipiridina) butilazol
ATE240329T1 (de) Zytotoxische pyrido(2,3,4-kl)acridinderivate, ihre herstellung und therapeutische verwendung
ATE257826T1 (de) Benzimidazolderivate und sie enthaltende medikamente
AU3387301A (en) Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
DE60009301D1 (en) Benzimidazolverbindungen
ECSP982641A (es) Ciertos acidos 5 - alquil-2-arilaminofenilaceticos y sus derivados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties